Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

For the longest time, it was assumed that 5-6% of kids had attention-deficit hyperactivity disorder (ADHD), but the rates are ...

Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a ...

Organizations that embrace neurodivergent leaders are discovering significant competitive advantages. Diverse teams ...

The role-playing app Character.AI lets teen users create their own AI chatbots to text with. What could go wrong?

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023.

It’s associated with increased rates of infant mortality, ADHD, dementia, depression, coronary heart disease and anemia. And ...

NYU Grossman School of Medicine offers a 12-month postdoctoral fellowship within the organizational skills training and ...

Mandy Teefey, co-founder of Wondermind and mother to Selena Gomez opens up about being misdiagnosed with bipolar disorder.

Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...

Experts call a key aspect of what McMurtry experiences when engaged in physical activity “hyperfocus,” and it’s an ...